US FDA Issues warnings on device fragments
This article was originally published in Clinica
The US FDA has issued a warning about the dangers of fragments of medical devices that can become unintentionally separated and remain in a patient after a surgical procedure. In a public heath notification, the agency says that these fragments, referred to as unretrieved device fragments (UDFs), can cause local tissue reaction, infection, perforation and obstruction of blood vessels, and death. During MRI procedures, magnetic fields can cause metallic fragments to migrate and radiofrequency fields can cause the fragments to heat, causing internal tissue damage or burns.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.